BBPL clearly understands the needs of animal health and productivity. The Company is continuously striving for the best of it by swiftly adapting to the current trends in vaccine production technologies. In this endeavour, the Company has technology tie ups with various premier institutions engaged in Veterinary Vaccines research. The new products in pipeline are vaccines against Pestes Des Petits Ruminants (PPR), Goat Pox and Bluetongue.
Furthermore, the Company also has plans to enhance the FMD vaccine production capacity up to 300 Million doses per annum by expanding the manufacturing facilities.